Inhibrx Biosciences (INBX) Earnings Date & Reports

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

INBX is expected to report earnings to fall 54.37% to -140 cents per share on May 28

Inhibrx Biosciences INBX Stock Earnings Reports

Q1'25

Est.

$-1.41

Q4'24

Missed

by $1.65

Q3'24

Missed

by $1.36

Q2'24

Beat

by $127.00

Q1'24

Est.

$-1.44

The last earnings report on March 17 showed earnings per share of -308 cents, missing the estimate of -144 cents. With 220.45K shares outstanding, the current market capitalization sits at 204.11M.

View a ticker or compare two or three

Compare

INBX